Broker’s Call: Adani Power (Neutral)

Why It Matters

The neutral call signals that Adani Power is positioned to benefit from rising electricity demand and a healthier distribution ecosystem, while still facing short‑term supply constraints that could affect earnings.

Key Takeaways

• Macquarie initiates coverage with neutral rating, $2.77 target per share.
• India's power demand hits 271 GW in May amid heatwave.
• Grid expansion plan totals ~$108 billion, adding 50 GW annual capacity.
• Discoms post historic $325 million profit, AT&C losses fall to 15%.
• Renewable generation drives 50 GW yearly capacity additions.

Pulse Analysis

Macquarie’s neutral rating on Adani Power reflects a nuanced view of India’s power landscape. The broker’s $2.77 target, derived from a 15‑times two‑year forward EV/EBITDA multiple, balances the company’s growth prospects against near‑term supply tightness. India’s electricity demand remains buoyant, with a May peak of 271 GW—an unprecedented level triggered by an intense heatwave—underscoring the need for additional generation and transmission capacity.

Supply constraints are becoming more pronounced as the grid operates with minimal headroom, especially during solar‑rich periods. To address this, the government and utilities are embarking on a record‑size grid expansion program valued at roughly $108 billion, targeting 50 GW of new capacity each year, predominantly from renewable sources. This massive capex cycle is expected to alleviate bottlenecks, improve reliability, and support the surge in industrial, data‑center, and residential cooling loads.

Perhaps the most transformative development is the turnaround in distribution company finances. Discoms reported a historic $325 million profit, while aggregate AT&C losses dropped to 15% from 23% in FY14, thanks to stricter surcharge enforcement and aggressive debt collection. This financial health boost reduces systemic risk, improves credit metrics, and creates a more attractive environment for investors eyeing the Indian power sector’s long‑term upside.